Keywords: بیماری روده ای عملکردی; Bloating; Functional Bowel Disease; Nonabsorbed; Xifaxan; AE; adverse event; IBS-D; diarrhea-predominant irritable bowel syndrome; TARGET; targeted, nonsystemic antibiotic rifaximin gut-selective evaluation of treatment for IBS-D; TID; three times daily;